He simultaneously served as Vice President and Senior Portfolio Manager at Chevy Chase Trust, where he was responsible for managing portfolios for high net worth individual and institutional clients
Frontiers in Pharmacology, 11, 627533
In a Phase Ib study for patients with Type 2 Diabetes (T2D), although no significant improvement in HbA1c levels was observed, pemvidutide still achieved a weight reduction of 8.5% at the end of a 12-week course compared to placebo
By removing geographic barriers, were reaching more diverse patient populations, driving faster enrollment, and generating high-quality data. Tyler Van Horn, CEO at Science 37 Through their collaboration, theyve supported 17 studies, enrolling nearly 1,700 patients and representing an average of 26% of the total study population per trial